Results

Total Results: 1,246 records

Showing results for "hepatitis c".
Users also searched for: hepatitis c

1121. Crosscutting-Horizon-Scan-High-Impact-1412 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/crosscutting-horizon-scan-high-impact-1412.pdf
      December 01, 2014 - HHSA290-2010-00006-C). … C virus infection, and mental health disorders. … Foreman C. … Inadomi J, Gunnarsson C, Rizzo JA, et al. … Grudzen C, Chen A, Richardson LD, et al.

1122. Section 4. Identifying Strategies | Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/final-reports/ptflow/section4.html
      July 01, 2018 - Successfully Used by Hospitals to Improve Patient Flow Appendix B: Implementation Plan Template Appendix C:

1123. CDS Connect Implementation Guide Draft (doc file)
      cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_USPSTF%20Statin%20Use%20for%20the%20Primary%20Prevention%20of%20CVD%20in%20Adults_Final.docx
      October 01, 2017 - Patient is likely to have adverse reactions to statins. c. … abnormal blood cholesterol, represented HDL-C < 40 mg/dL or LDL-C > 130 mg/dL Grade B and C "Diabetes … " Type 1 and Type 2 Diabetes Grade B and C "Hypertension" high blood pressure Grade B and C " … the work group, not all liver conditions clearly exclude a recommendation for statin therapy (e.g., Hepatitis … B and C).

1124. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
      September 01, 2015 - c. Is it subject to 510(k) clearance or De Novo pathway? … c. … c. … c. … For example, each protease inhibitor for treatment of hepatitis C virus would be tracked individually

1125. Horizon Scanning Protocol and Operations Manual September 2015 Revision (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/ahrq-healthcare-horizon-scan-protocol-operations-manual-151001.pdf
      September 01, 2015 - c. Is it subject to 510(k) clearance or De Novo pathway? … c. … c. … c. … For example, each protease inhibitor for treatment of hepatitis C virus would be tracked individually

1126. Individualized Drug Interaction Alerts - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r21hs023826-malone-final-report-2017.pdf
      January 01, 2017 - Alerts - Final Report Individualized Drug Interaction Alerts Investigators: Daniel C. … Varicella - Live Vaccines / Live Vaccines 2568 Potassium Preps / Potassium Sparing Diuretics 2545 Hepatitis … Law V, Knox C, Djoumbou Y, et al. DrugBank 4.0: shedding new light on drug metabolism.

1127. Schedule of Visits and Use of Telemedicine for Routine Antenatal Care: A Systematic Review Protocol (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/antenatal-care.pdf
      January 01, 2020 - trimester laboratory tests (complete blood count, blood type and screen, urinalysis, and testing for HIV, hepatitis … Michie S, Johnston M, Abraham C, et al. … Carroll C, Booth A, Leaviss J, et al. "Best fit" framework synthesis: refining the method. … Lewin S, Booth A, Glenton C, et al.

1128. Population Denominator Data Sources and Data for Use with HCUP Databases (Updated with 2021 Population Data) (pdf file)
      hcup-us.ahrq.gov/reports/methods/MS2022-03-PopulationReport.pdf
      December 15, 2022 - ..................................................................................... 38 Appendix C. … examinations (e.g., blood pressure, lower extremity disease, obesity, etc.) and laboratory tests (e.g., hepatitis … doc_id=385937 (HCUP 12/15/22) 39 Population Denominators APPENDIX C. … Non-Institutionalized Populations Time Dimension Differences Uniform Payer Tangent Other Considerations Appendix C.

1129. Population Denominator Data Sources and Data for Use with HCUP Databases (Updated with 2020 Population Data) (pdf file)
      hcup-us.ahrq.gov/reports/methods/MS-2021-04-PopulationReport.pdf
      January 01, 2021 - ..................................................................................... 38 Appendix C. … examinations (e.g., blood pressure, lower extremity disease, obesity, etc.) and laboratory tests (e.g., hepatitis … doc_id=385937 (HCUP 12/15/21) 39 Population Denominators APPENDIX C. … Non-Institutionalized Populations Time Dimension Differences Uniform Payer Tangent Other Considerations Appendix C.

1130. Archived: Evidence Summary: Drug Use, Illicit: Primary Care Interventions for Children and Adolescents | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary24/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
      March 11, 2014 - Polen MR, Whitlock EP, Wisdom JP, Nygren P, Bougatsos C. … [PMID: 20722153] Barnett E, Sussman S, Smith C, Rohrbach LA, Spruijt-Metz D. … [PMID: 16437511] Jackson C, Geddes R, Haw S, Frank J. … Integrated prevention services for HIV infection, viral hepatitis, sexually transmitted diseases, and

1131. hemangioma-protocol-141223 (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/infantile-hemangioma_research-protocol.pdf
      December 23, 2014 - We will request Scientific Information Packets (SIP) (Appendix C) and regulatory information addressing … C. … Kilcline C, Frieden IJ. Infantile hemangiomas: how common are they? … Leonardi-Bee J, Batta K, O'Brien C, et al. … Source: www.effectivehealthcare.ahrq.gov Published online: December 23, 2014 29 Appendix C.

1132. Guide-Infection-Prevention (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/quality-resources/tools/cauti-ltc/modules/resources/guides/guide-infection-prevention.pdf
      March 01, 2017 - ▪ MRSA (methicillin-resistant Staphylococcus aureus) ▪ VRE (vancomycin-resistant Enterococcus) ▪ C. … ▪ MRSA (methicillin-resistant Staphylococcus aureus) ▪ VRE (vancomycin-resistant Enterococcus) ▪ C. … resident, including— ▪ Nausea ▪ Diarrhea ▪ Allergic reactions ▪ Antibiotic-related infection (C. … These work practices include— ▪ Offering the hepatitis B vaccine to any staff member who has the

1133. Section 8: The Care Management Evidence Base | Agency for Healthcare Research and Quality
      www.ahrq.gov/patient-safety/settings/long-term-care/resource/hcbs/medicaidmgmt/mm8.html
      October 01, 2014 - Gilmer TP, Philis-Tsimikas A, Walker C. … Chase HP, Pearson JA, Wightmlan C, et al. … Cherry JC, Moffatt TP, Rodriguez C, et al.

1134. Nis 2003 Summarystats 10Pct Severity A (pdf file)
      hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2003_SummaryStats_10PCT_SEVERITY_A.PDF
      January 01, 2003 - : D&C,CONIZATION&RADIO-IMPLNT,MALIG W MCC <= 10 **.** 3640: D&C,CONIZATION EXC FOR MALIGNANCY W/O CC … 120 0.02 3641: D&C,CONIZATION EXC FOR MALIGNANCY W CC 57 0.01 3642: D&C,CONIZATION EXC FOR MALIGNANCY … /OR D&C W MCC <= 10 **.** 3750: VAG DEL W O.R EX STERIL &/OR D&C W/O CC 38 0.00 3751: VAG DEL W O.R … W/O CC 315 0.04 3801: ABORTION W/O D&C W CC 76 0.01 3802: ABORTION W/O D&C W MCC <= 10 **.** 3810: … ABORTN W D&C,ASP CURETT,HYSTEROT W/O CC 476 0.06 3811: ABORTN W D&C,ASP CURETT,HYSTEROT W CC 120 0.02

1135. Implications for the Guide | Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/final-reports/ptfamilyscan/ptfamily5.html
      July 01, 2018 - Appendix A: Draft Key Informant Interview Protocol Appendix B: Summary of Search Terms Appendix C:

1136. Archived: Final Evidence Review: Gonorrhea: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-review40/gonorrhea-screening-2005
      May 15, 2005 - The risk factors examined included age less than 20 years, marital status, history of STD or hepatitis … Sloan NL, Winikoff B, Haberland N, Coggins C, Elias C. … Banikarim C, Chacko MR, Wiemann CM, Smith PB. … Todd CS, Haase C, Stoner BP. … Gift T, Walsh C, Haddix A, Irwin KL.

1137. Background | Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/final-reports/ptmgmt/background.html
      July 01, 2018 - processes provided (A and B) influence the patient's ability and motivation to improve his or her own care (C)

1138. Section 3. Measuring Emergency Department Performance | Agency for Healthcare Research and Quality
      www.ahrq.gov/research/findings/final-reports/ptflow/section3.html
      April 01, 2020 - Successfully Used by Hospitals to Improve Patient Flow Appendix B: Implementation Plan Template Appendix C:

1139. THE HCUP NATIONWIDE READMISSIONS DATABASE (NRD), 2015
      hcup-us.ahrq.gov/db/nation/nrd/Introduction_NRD_2010-2015.jsp
      January 01, 2015 - STATE-SPECIFIC RESTRICTIONS Table C.1. … Table C.1. … Mycoses 10,755 27.56 28.10 2.0 5: HIV infection 7,495 26.99 27.66 2.5 6: Hepatitis … including parasitic 4,117 13.46 14.09 4.7 9: Sexually transmitted infections (not HIV or hepatitis … Andrews R, Kassed C, Nagamine M.

1140. 2018 National Healthcare Quality and Disparities Report Detailed Methods for the Medical Expenditure Panel Survey (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/2018qdr-mepsmethods.pdf
      January 01, 2020 - disorders (drug and alcohol), chronic obstructive pulmonary disease, asthma, chronic kidney disease, HIV, hepatitis … Zahn C, Sangl J, Bierman AS, et al.